Dr. Bazhenova on Considering Factors to Treat Non-Driver Patients With NSCLC With Bevacizumab

September 1, 2017
Lyudmila A. Bazhenova, MD
Lyudmila A. Bazhenova, MD

Volume 1, Issue 1

Lyudmila A. Bazhenova, MD, medical oncologist, professor of medicine, UC San Diego Health, discusses the factors to take into consideration when treating a patient with non-driver non–small cell lung cancer with bevacizumab (Avastin).